Greenwich LifeSciences Inc.

GLSI | NASDAQ

Price Alert Chart Builder DCF Calculator

$14.65

-$1.70 (-10.40%)

At close: Nov 5, 2026, 4:00 PM ET

$15.23

+$0.58 (+3.96%)

After-hours: Nov 5, 2026, 5:04 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $215.04M

Enterprise Value $231.11M

Beta 1.55

Average Volume 145.71K

Shares Outstanding (Diluted) 14.62M

Shares Change YoY 9.35%

Institutional Ownership 11.66%

Exchange NASDAQ

ISIN US3968791083

Price Performance

Price Change 1M -7.2%

Price Change 3M 2.9%

Price Change 6M -38.0%

Price Change YTD -30.3%

Price Change 1Y 78.2%

Price Change 3Y 40.5%

Price Change 5Y -60.9%

1M CAGR (ann.) -11.5%

1Y CAGR (ann.) 79.1%

5Y CAGR (ann.) -13.7%

All-Time CAGR 21.5%

Valuation

PE Ratio -10.62

Forward PE N/A

PEG Ratio 0.79

Forward PEG -0.79

PS Ratio N/A

Forward PS 27.40

PB Ratio 76.99

P/FCF Ratio -19.22

P/Adj. FCF Ratio -14.07

P/OCF Ratio -19.24

EV/Sales N/A

EV/EBIT -10.66

EV/EBITDA -10.66

EV/FCF -18.51

Earnings Yield -9.4%

FCF Yield -5.2%

Adj. FCF Yield -7.1%

Financial Health

Net Cash $8.88M

Total Debt $0

Cash & Short-Term Investments $8.88M

Total Assets $8.88M

Current Ratio 1.54

Quick Ratio 1.54

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 2.10

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -36.6%

Returns

Return on Assets -244.3%

Return on Equity -793.8%

Return on Invested Capital -701.5%

Return on Capital Employed -701.5%

Return on Tangible Assets -244.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -30.5%

EPS CAGR 5Y -29.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y -30.8%

FCF CAGR 5Y -20.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 247.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 13, 2026

EPS Estimate (next Q) -$0.30

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $50.00

Price Target Upside 205.8%

Cash Flow

Operating Cash Flow $-12.49M

Free Cash Flow $-12.49M

Adj. Free Cash Flow $-17.06M

FCF Per Share -$0.85

OCF Per Share -$0.85

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-21.87M

EBITDA $-21.68M

Net Income $-21.68M

EPS (Diluted) -$1.54

Revenue / Employee N/A

Profit / Employee $-1.67M

Employees 13